Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance. / Petersen, Claus Leth; Nielsen, Jens Rokkedal; Petersen, Bodil Laub; Kjaer, Andreas.

In: Cardiology, Vol. 100, No. 1, 2003, p. 23-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Petersen, CL, Nielsen, JR, Petersen, BL & Kjaer, A 2003, 'Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance.', Cardiology, vol. 100, no. 1, pp. 23-8. https://doi.org/10.1159/000072388

APA

Petersen, C. L., Nielsen, J. R., Petersen, B. L., & Kjaer, A. (2003). Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance. Cardiology, 100(1), 23-8. https://doi.org/10.1159/000072388

Vancouver

Petersen CL, Nielsen JR, Petersen BL, Kjaer A. Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance. Cardiology. 2003;100(1):23-8. https://doi.org/10.1159/000072388

Author

Petersen, Claus Leth ; Nielsen, Jens Rokkedal ; Petersen, Bodil Laub ; Kjaer, Andreas. / Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance. In: Cardiology. 2003 ; Vol. 100, No. 1. pp. 23-8.

Bibtex

@article{ff2b3dc0accd11ddb538000ea68e967b,
title = "Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance.",
abstract = "AIM: The study was designed to assess (1) the time course of catecholaminergic activation in acute myocardial infarction (AMI) as estimated by adrenaline (ADR) and noradrenaline (NOR) concentrations, and (2) to relate activation of these hormones to predict the outcome of cardiac performance. PATIENTS AND METHODS: Eighteen patients with first AMI were studied. Blood samples were drawn within the first 4-18 h, after 18-24 h, on day 2, day 3 and on day 6 as well as after 1 year. Radionuclide ventriculography was performed on the day of discharge and after 1 year to determine left-ventricular ejection fraction (LVEF). RESULTS: In the study group as a whole, the concentrations of ADR decreased from (mean +/- SEM) 0.80 +/- 0.12 nmol/l on admission to 0.33 +/- 0.03 nmol/l at discharge (p < 0.05). NOR decreased from 4.19 +/- 0.78 to 2.44 +/- 0.33 nmol/l (p < 0.05). Initial peak concentrations of both ADR and NOR on admission were correlated to LVEF at discharge (r = -0.56, p < 0.05 and r = -0.72, p < 0.05, respectively). If NOR was normal (<3 nmol/l) at admission, the LVEF was normal or almost normal (= 0.46) at discharge. The mean plasma level of ADR and NOR after 1 year follow-up was 0.34 +/- 0.04 and 1.95 +/- 0.25 nmol/l, respectively. The values after 1 year were unchanged compared to values at discharge, at day 6 (n.s.). Mean LVEF was 0.50 +/- 0.03 (range: 0.23-0.69) at discharge and unchanged 0.46 +/- 0.05 (range: 0.18-0.72) at 1 year follow-up (n.s.). During hospitalisation, the group with LVEF <0.50 had an 86% higher initial ADR and an 82% higher initial NOR concentration compared to values in patients with LVEF >0.50 (p < 0.05). CONCLUSION: (1) Catecholaminergic activation, as measured by plasma ADR and NOR in AMI, is acute and restricted to the first 5 days. Thereafter, the hormone levels are normal and stable. (2) The magnitude of the early catecholaminergic activation correlates with left ventricular systolic performance. (3) Normal NOR values at admittance predicts normal or almost normal LVEF at discharge.",
author = "Petersen, {Claus Leth} and Nielsen, {Jens Rokkedal} and Petersen, {Bodil Laub} and Andreas Kjaer",
note = "Keywords: Adult; Aged; Epinephrine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Radionuclide Ventriculography; Stroke Volume; Time Factors; Ventricular Function, Left",
year = "2003",
doi = "10.1159/000072388",
language = "English",
volume = "100",
pages = "23--8",
journal = "Cardiologia",
issn = "0008-6312",
publisher = "S Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Catecholaminergic activation in acute myocardial infarction: time course and relation to left ventricular performance.

AU - Petersen, Claus Leth

AU - Nielsen, Jens Rokkedal

AU - Petersen, Bodil Laub

AU - Kjaer, Andreas

N1 - Keywords: Adult; Aged; Epinephrine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Radionuclide Ventriculography; Stroke Volume; Time Factors; Ventricular Function, Left

PY - 2003

Y1 - 2003

N2 - AIM: The study was designed to assess (1) the time course of catecholaminergic activation in acute myocardial infarction (AMI) as estimated by adrenaline (ADR) and noradrenaline (NOR) concentrations, and (2) to relate activation of these hormones to predict the outcome of cardiac performance. PATIENTS AND METHODS: Eighteen patients with first AMI were studied. Blood samples were drawn within the first 4-18 h, after 18-24 h, on day 2, day 3 and on day 6 as well as after 1 year. Radionuclide ventriculography was performed on the day of discharge and after 1 year to determine left-ventricular ejection fraction (LVEF). RESULTS: In the study group as a whole, the concentrations of ADR decreased from (mean +/- SEM) 0.80 +/- 0.12 nmol/l on admission to 0.33 +/- 0.03 nmol/l at discharge (p < 0.05). NOR decreased from 4.19 +/- 0.78 to 2.44 +/- 0.33 nmol/l (p < 0.05). Initial peak concentrations of both ADR and NOR on admission were correlated to LVEF at discharge (r = -0.56, p < 0.05 and r = -0.72, p < 0.05, respectively). If NOR was normal (<3 nmol/l) at admission, the LVEF was normal or almost normal (= 0.46) at discharge. The mean plasma level of ADR and NOR after 1 year follow-up was 0.34 +/- 0.04 and 1.95 +/- 0.25 nmol/l, respectively. The values after 1 year were unchanged compared to values at discharge, at day 6 (n.s.). Mean LVEF was 0.50 +/- 0.03 (range: 0.23-0.69) at discharge and unchanged 0.46 +/- 0.05 (range: 0.18-0.72) at 1 year follow-up (n.s.). During hospitalisation, the group with LVEF <0.50 had an 86% higher initial ADR and an 82% higher initial NOR concentration compared to values in patients with LVEF >0.50 (p < 0.05). CONCLUSION: (1) Catecholaminergic activation, as measured by plasma ADR and NOR in AMI, is acute and restricted to the first 5 days. Thereafter, the hormone levels are normal and stable. (2) The magnitude of the early catecholaminergic activation correlates with left ventricular systolic performance. (3) Normal NOR values at admittance predicts normal or almost normal LVEF at discharge.

AB - AIM: The study was designed to assess (1) the time course of catecholaminergic activation in acute myocardial infarction (AMI) as estimated by adrenaline (ADR) and noradrenaline (NOR) concentrations, and (2) to relate activation of these hormones to predict the outcome of cardiac performance. PATIENTS AND METHODS: Eighteen patients with first AMI were studied. Blood samples were drawn within the first 4-18 h, after 18-24 h, on day 2, day 3 and on day 6 as well as after 1 year. Radionuclide ventriculography was performed on the day of discharge and after 1 year to determine left-ventricular ejection fraction (LVEF). RESULTS: In the study group as a whole, the concentrations of ADR decreased from (mean +/- SEM) 0.80 +/- 0.12 nmol/l on admission to 0.33 +/- 0.03 nmol/l at discharge (p < 0.05). NOR decreased from 4.19 +/- 0.78 to 2.44 +/- 0.33 nmol/l (p < 0.05). Initial peak concentrations of both ADR and NOR on admission were correlated to LVEF at discharge (r = -0.56, p < 0.05 and r = -0.72, p < 0.05, respectively). If NOR was normal (<3 nmol/l) at admission, the LVEF was normal or almost normal (= 0.46) at discharge. The mean plasma level of ADR and NOR after 1 year follow-up was 0.34 +/- 0.04 and 1.95 +/- 0.25 nmol/l, respectively. The values after 1 year were unchanged compared to values at discharge, at day 6 (n.s.). Mean LVEF was 0.50 +/- 0.03 (range: 0.23-0.69) at discharge and unchanged 0.46 +/- 0.05 (range: 0.18-0.72) at 1 year follow-up (n.s.). During hospitalisation, the group with LVEF <0.50 had an 86% higher initial ADR and an 82% higher initial NOR concentration compared to values in patients with LVEF >0.50 (p < 0.05). CONCLUSION: (1) Catecholaminergic activation, as measured by plasma ADR and NOR in AMI, is acute and restricted to the first 5 days. Thereafter, the hormone levels are normal and stable. (2) The magnitude of the early catecholaminergic activation correlates with left ventricular systolic performance. (3) Normal NOR values at admittance predicts normal or almost normal LVEF at discharge.

U2 - 10.1159/000072388

DO - 10.1159/000072388

M3 - Journal article

C2 - 12975542

VL - 100

SP - 23

EP - 28

JO - Cardiologia

JF - Cardiologia

SN - 0008-6312

IS - 1

ER -

ID: 8465088